NFAT, immunity and cancer: A transcription factor comes of age

Nature Reviews Immunology

Volumn 10, Issue 9, 2010, Pages 645-656

  Müller, Martin R ^a   Rao, Anjana ^b,c,d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CASEIN KINASE I; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIN DEPENDENT KINASE 4; CYCLOOXYGENASE 2; CYCLOSPORIN A; GLYCOGEN SYNTHASE KINASE 3; INOSITOL 1,4,5 TRISPHOSPHATE; LAT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; VASCULOTROPIN A;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; B CELL LYMPHOMA; B LYMPHOCYTE; BREAST CANCER; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DENDRITIC CELL; DNA BINDING; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; MAST CELL; MEGAKARYOCYTE; MELANOMA; NATURAL KILLER T CELL; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TH17 CELL; TUMOR GROWTH;

ANIMALS; HUMANS; NEOPLASMS; NFATC TRANSCRIPTION FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77956175013     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2818     Document Type: Review

References (120)

1. Shaw, J. P. et al. Identification of a putative regulator of early T cell activation genes. Science 241, 202-205 (1988).
2. Flanagan, W. M., Corthesy, B., Bram, R. J. & Crabtree, G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803-807 (1991).
3. Jain, J., McCaffrey, P. G., Valge-Archer, V. E. & Rao, A. Nuclear factor of activated T cells contains Fos and Jun. Nature 356, 801-804 (1992).
4. Jain, J. et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365, 352-355 (1993).
5. McCaffrey, P. G. et al. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262, 750-754 (1993).
6. Northrop, J. P. et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502 (1994).
7. Hoey, T., Sun, Y. L., Williamson, K. & Xu, X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2, 461-472 (1995).
8. Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815 (1991).
9. Hogan, P. G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232 (2003).
10. Macian, F. NFAT proteins: key regulators of T-cell development and function. Nature Rev. Immunol. 5, 472-484 (2005).
11. Zanoni, I. et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 264-268 (2009)
12. 2+-NFAT signalling in DCs.
13. Shukla, U., Hatani, T., Nakashima, K., Ogi, K. & Sada, K. Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT. J. Biol. Chem. 284, 33719-33728 (2009).
14. Crist, S. A., Sprague, D. L. & Ratliff, T. L. Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes. Blood 111, 3553-3561 (2008).
15. +-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241-256 (2009).
16. Winslow, M. M. et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771-782 (2006).
17. Heit, J. J. et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function. Nature 443, 345-349 (2006).
18. Horsley, V., Aliprantis, A. O., Polak, L., Glimcher, L. H. & Fuchs, E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell 132, 299-310 (2008).
19. Robbs, B. K., Cruz, A. L., Werneck, M. B., Mognol, G. P. & Viola, J. P. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol. Cell. Biol. 28, 7168-7181 (2008).
20. Mancini, M. & Toker, A. NFAT proteins: emerging roles in cancer progression. Nature Rev. Cancer 9, 810-820 (2009).
21. +- calcineurin-NFAT signaling. Cell 138, 210, 210.e1 (2009).
22. Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S. & Kwon, H. M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA 96, 2538-2542 (1999).
23. Lopez-Rodriguez, C., Aramburu, J., Rakeman, A. S. & Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl Acad. Sci. USA 96, 7214-7219 (1999).
24. Lopez-Rodriguez, C. et al. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc. Natl Acad. Sci. USA 101, 2392-2397 (2004).
25. Lopez-Rodriguez, C. et al. Bridging the NFAT and NF-κB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15, 47-58 (2001).
26. Hogan, P. G., Lewis, R. & Rao, A. Molecular basis of calcium signalling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28, 491-533 (2010).
27. Feske, S. Calcium signalling in lymphocyte activation and disease. Nature Rev. Immunol. 7, 690-702 (2007).
28. Aramburu, J. et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129-2133 (1999).
29. Li, H., Rao, A. & Hogan, P. G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. (in the press).
30. Müller, M. R. et al. Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development. Proc. Natl Acad. Sci. USA 106, 7034-7039 (2009).
31. Arron, J. R. et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600 (2006).
32. Gwack, Y. et al. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441, 646-650 (2006). References 30 and 31 identified DYRKs as kinases of NFAT.
33. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. & Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1934 (1997).
34. Okamura, H. et al. A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol. Cell. Biol. 24, 4184-4195 (2004).
35. Zhou, B. et al. Regulation of the murine Nfatc1 gene by NFATc2. J. Biol. Chem. 277, 10704-10711 (2002).
36. Chuvpilo, S. et al. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16, 881-895 (2002).
37. Huang, G. N. et al. NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins. Science 319, 476-481 (2008).
38. Willingham, A. T. et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309, 1570-1573 (2005).
39. Wu, W. et al. Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3. J. Biol. Chem. 281, 10682-10690 (2006).
40. Yoeli-Lerner, M. et al. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20, 539-550 (2005).
41. Yoeli-Lerner, M., Chin, Y. R., Hansen, C. K. & Toker, A. Akt/protein kinase b and glycogen synthase kinase-3β signaling pathway regulates cell migration through the NFAT1 transcription factor. Mol. Cancer Res. 7, 425-432 (2009).
42. Terui, Y., Saad, N., Jia, S., McKeon, F. & Yuan, J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279, 28257-28265 (2004).
43. Nayak, A. et al. Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J. Biol. Chem. 284, 10935-10946 (2009).
44. Olabisi, O. A. et al. Regulation of transcription factor NFAT by ADP-ribosylation. Mol. Cell. Biol. 28, 2860-2871 (2008).
45. Valdor, R. et al. Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells. Mol. Immunol. 45, 1863-1871 (2008).
46. Sun, Z. et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288, 2369-2373 (2000).
47. Shen, F., Hu, Z., Goswami, J. & Gaffen, S. L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138-24148 (2006).
48. Gomez-Rodriguez, J. et al. Differential expression of interleukin-17A and-17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 31, 587-597 (2009).
49. Ghosh, S. et al. Hyperactivation of nuclear factor of activated T cells (NFAT1) in T cells attenuates severity of murine autoimmune encephalitis. Proc. Natl Acad. Sci. USA (in the press).
50. H-17 cells. Nature Immunol. 10, 167-175 (2009).
51. Ho, I. C., Hodge, M. R., Rooney, J. W. & Glimcher, L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983 (1996).
52. Fehr, T. et al. A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo. Blood 11 5, 1280-1287 (2010).
53. Baine, I., Abe, B. T. & Macian, F. Regulation of T-cell tolerance by calcium/NFAT signaling. Immunol. Rev. 231, 225-240 (2009).
54. Macian, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731 (2002).
55. Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunol. 5, 255-265 (2004).
56. Puga, I., Rao, A. & Macian, F. Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 29, 193-204 (2008).
57. Hsiao, H. W. et al. Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy. Immunity 31, 72-83 (2009).
58. Nurieva, R. I. et al. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32, 670-680 (2010).
59. Soto-Nieves, N. et al. Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J. Exp. Med. 206, 867-876 (2009).
60. Josefowicz, S. Z. & Rudensky, A. Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616-625 (2009).
61. Lal, G. et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 182, 259-273 (2009).
62. Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nature Immunol. 9, 194-202 (2008).
63. Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812 (2010).
64. Huehn, J., Polansky, J. K. & Hamann, A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nature Rev. Immunol. 9, 83-89 (2009).
65. + regulatory T cells. J. Exp. Med. 201, 181-187 (2005).
66. Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
67. Hu, H., Djuretic, I., Sundrud, M. S. & Rao, A. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol. 28, 329-332 (2007).
68. - helper T cells. J. Leukoc. Biol. 83, 708-717 (2008).
69. Goodridge, H. S., Simmons, R. M. & Underhill, D. M. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 178, 3107-3115 (2007).
70. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263 (1998).
71. Monticelli, S., Solymar, D. C. & Rao, A. Role of NFAT proteins in IL13 gene transcription in mast cells. J. Biol. Chem. 279, 36210-36218 (2004).
72. Klein, M. et al. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J. Immunol. 177, 6667-6674 (2006).
73. Walczak-Drzewiecka, A., Ratajewski, M., Wagner, W. & Dastych, J. HIF-1α is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J. Immunol. 181, 1665-1672 (2008).
74. Ulleras, E. et al. NFAT but not NF-κB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells. Blood 111, 3081-3089 (2008).
75. Hardy, R. R. B-1 B cell development. J. Immunol. 177, 2749-2754 (2006).
76. Berland, R. & Wortis, H. H. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl Acad. Sci. USA 100, 13459-13464 (2003).
77. Winslow, M. M., Gallo, E. M., Neilson, J. R. & Crabtree, G. R. The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity 24, 141-152 (2006).
78. Haylett, R. S., Koch, N. & Rink, L. MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells. Eur. J. Immunol. 39, 1947-1955 (2009).
79. De Gorter, D. J., Vos, J. C., Pals, S. T. & Spaargaren, M. The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral. J. Immunol. 178, 1405-1414 (2007).
80. Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
81. Lazarevic, V. et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nature Immunol. 10, 306-313 (2009).
82. Ferroni, P., Santilli, F., Guadagni, F., Basili, S. & Davi, G. Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis. Curr. Med. Chem. 14, 2170-2180 (2007).
83. Gallo, E. M., Ho, L., Winslow, M. M., Staton, T. L. & Crabtree, G. R. Selective role of calcineurin in haematopoiesis and lymphopoiesis. EMBO Rep. 9, 1141-1148 (2008).
84. + cells: regulation of Fas ligand gene expression in megakaryocytes. Exp. Hematol. 35, 757-770 (2007).
85. Baksh, S. et al. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 10, 1071-1081 (2002).
86. Carvalho, L. D. et al. The NFAT1 transcription factor is a repressor of cyclin A2 gene expression. Cell Cycle 6, 1789-1795 (2007).
87. Ranger, A. M., Oukka, M., Rengarajan, J. & Glimcher, L. H. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9, 627-635 (1998).
88. Kondo, E. et al. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor. Eur. J. Immunol. 33, 1-11 (2003).
89. Neal, J. W. & Clipstone, N. A. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278, 17246-17254 (2003).
90. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
91. Jauliac, S. et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nature Cell Biol. 4, 540-544 (2002).
92. Chen, M. & O'Connor, K. L. Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24, 5125-5130 (2005).
93. Liu, S. et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15, 539-550 (2009).
94. Yiu, G. K. & Toker, A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 281, 12210-12217 (2006).
95. Zhang, H. et al. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 69, 5441-5449 (2009).
96. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105, 863-875 (2001).
97. Nagy, J. A., Dvorak, A. M. & Dvorak, H. F. VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2, 251-275 (2007).
98. Dvorak, H. F. Discovery of vascular permeability factor (VPF). Exp. Cell Res. 312, 522-526 (2006).
99. Jinnin, M. et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nature Med. 14, 1236-1246 (2008).
100. Hernandez, G. L. et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193, 607-620 (2001).
101. Baek, K. H. et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126-1130 (2009).
102. Qin, L. et al. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol. Cancer Res. 4, 811-820 (2006).
103. Kulkarni, R. M., Greenberg, J. M. & Akeson, A. L. NFATc1 regulates lymphatic endothelial development. Mech. Dev. 126, 350-365 (2009).
104. Norrmen, C. et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439-457 (2009).
105. Marafioti, T. et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br. J. Haematol. 128, 333-342 (2005).
106. Akimzhanov, A. et al. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. Am. J. Pathol. 172, 215-224 (2008).
107. Glud, S. Z. et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106, 3546-3552 (2005). This is the first paper to show that NFAT can function as a tumour suppressor.
108. Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lin-Lee, Y. C. & Ford, R. J. Constitutive NF-κB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106, 3940-3947 (2005).
109. Fu, L. et al. Constitutive NF-kB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107, 4540-4548 (2006).
110. Medyouf, H. et al. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nature Med. 13, 736-741 (2007).
111. + leukemia cells upon inhibition of Bcr-Abl. Cancer Cell 18, 74-87 (2010).
112. 2+/calcineurin signaling pathway. EMBO J. 25, 3714-3724 (2006).
113. Koenig, A. et al. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology 138, 1189-1199 (2010)
114. 2+/NFAT- dependent pathways. Oncogene 26, 7380-7385 (2007).
115. Flockhart, R. J., Armstrong, J. L., Reynolds, N. J. & Lovat, P. E. NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma. Br. J. Cancer 101, 1448-1455 (2009).
116. Sales, K. J. et al. Prostaglandin F(2α)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim. Biophys. Acta 1793, 1917-1928 (2009).
117. Sales, K. J. et al. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2α-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. Am. J. Pathol. 176, 435-445, 2010
118. Muller, M. R. & Rao, A. Linking calcineurin activity to leukemogenesis. Nature Med. 13, 669-671 (2007).
119. Noguchi, H. et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nature Med. 10, 305-309 (2004).
120. Roehrl, M. H. et al. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc. Natl Acad. Sci. USA 101, 7554-7559 (2004).